MedCity News18d
FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products
Moderna’s messenger RNA vaccine for respiratory syncytial virus (RSV) is now FDA approved, a regulatory decision that comes nearly a year after GSK and Pfizer won regulatory approvals for their ...
USA Today17d
FDA approves Moderna's RSV vaccine, its second marketed product
The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.
CNN17d
FDA approves Moderna’s mRNA RSV vaccine for older adults
The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name of ...
The Business Journals18d
Moderna notches second product approval with new RSV vaccine
The Cambridge drugmaker has finally succeeded in landing its second product approval from the U.S. Food and Drug Administration after its Covid-19 vaccine. Moderna Inc. has landed its second ...
Reuters17d
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product. Moderna's vaccine was approved for ...
CNN17d
FDA approves Moderna’s mRNA RSV vaccine for older adults
Moderna’s shot is the third RSV vaccine for people 60 and older that’s gotten the green light from the FDA and the first mRNA vaccine among them. It’s the company’s second product to ...